共 50 条
- [31] KINETICS OF JAK2 V617F MUTATION IN FIVE JAK2 POSITIVE MDS PATIENTS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 462 - 462
- [32] Neutrophilia and the JAK2 V617F Mutation [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (01) : 437 - 438
- [33] Splenomegaly and the JAK2 V617F mutation [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 37 : E45 - E46
- [34] Genetic Basis of MPN: Beyond JAK2-V617F [J]. Current Hematologic Malignancy Reports, 2013, 8 : 299 - 306
- [35] Genetic Basis of MPN: Beyond JAK2-V617F [J]. CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) : 299 - 306
- [37] Autologous reconstitution leading to sustained JAK2-V617F negativity post allogeneic hematopoietic stem cell transplant in JAK2-V617F positive myelofibrosis [J]. Bone Marrow Transplantation, 2015, 50 : 1480 - 1482
- [39] COEXISTENCE OF POLYCITHEMYA VERA JAK2 V617F-POSITIVE AND MONOCLONAL GAMMOPATHY [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 583 - 583
- [40] A Prolonged Low Level JAK2 V617F Is Significant In Clinically Suspicious Myeloproliferative Neoplasms (MPN) [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 957 - 958